制药验证文件-洁净压缩空气GMP评估(英文版)
EUGMP-中英文对照[1]
![EUGMP-中英文对照[1]](https://img.taocdn.com/s3/m/ed974fef59eef8c75ebfb3e2.png)
EU GMP ANNEX 1 MANUFACTURE OF STERILE MEDICINAL PRODUCTS (中英文对照)(a) These are average values. (一)这些都是平均值。
(b) Individual settle plates may be exposed for less than 4 hours. (二)单个沉降皿放置的时间可以少于4小时。
20. Appropriate alert and action limits should be set for the results of particulate and microbiological monitoring. If these limits are exceeded operating procedures should prescribe corrective action。
对尘埃粒子和微生物的监控结果,要设置适当的警戒限度和行动限度。
当超出这些限度时,操作规程应说明需要采取的措施。
Isolator technology 隔离技术21. The utilisation of isolator technology to minimize human interventions in processing areas may result in a significant decrease in the risk of microbiological contamination of aseptically manufactured products from the environment. There are many possible designs of isolators and transfer devices. The isolator and the background environment should be designed so that the required air quality for the respective zones can be realised. Isolators are constructed of various materials more or less prone to puncture and leakage. Transfer devices may vary from a single door to double door designs to fully sealed systems incorporating sterilization mechanisms. 在生产区采用人员方面的隔离技术,在无菌产品的生产中,会显著降低周围环境微生物污染的风险。
制药验证文件-洁净空压机验证方案(英文版)

Qualification Protocol for New Air Compressor (COMP04)1. Short Description of Project / Facility / System1.1 Project DescriptionAs part of the “Extension of Production Facility, ChangPing” Project (EPCP, No. CNPHCP200502), a new Air Compressor COMP04 will be installed in the existing utilities area for the complementary production of compressed air.For general information, reference is made to:EPCP_11_06_INFRA_URS (current version)●INFRA URS,EPCP_01_00_HLD_URS (current version)●Project URS,EPCP_01_00_HLD_QMP (current version)●Project Qualification Master Plan,EPCP_01_00_HLD_QNA (current version)●Qualification Need Assessment,●Functional Risk Assessment EPCP_11_03_CA_FRA_2.0EPCP - CR 0238●Change request (new compressor)1.2 Functional Description for the ZT compressor with IMD dryer.NB. For the complete functionality of the CA system refer to the functional specification EPCP_11_03_CA_FS in its current version.Air drawn in through air filter (AF) and the open inlet valve of the unloader assembly (UA) is compressed in the low-pressure compressor element (El) and discharged to the intercooler (Ci).The cooled air is further compressed in the high-pressure compressor element (Eh) and discharged through the pulsation damper (AS) and the after cooler (Ca).A check valve (CV) is provided downstream of the pulsation damper (AS).When the compressor switches to unload operation, the air trapped in the pulsation damper and the high-pressure element is blown off via the blow-off silencer (US).The check valve (CV) prevents compressed air downstream the check valve to be blown off.Flow diagramAF Air filter (1) IMD bypass valve M4 Gear motor, IMD AS Pulsation damper (2) IMD air inlet valve EWD ElectronicCV Check valve drain, inlet airUS Blow-off silencer (3) DemisterCa After cooler with integrated drain (4) Nozzle Car Regeneration air cooler, IMD collector (5) IMD outlet valve FN Fan, regeneration air IS Inlet silencer cooler to air outlet valve (customer’sUA Unloader assembly installation)EWDa Electronic drain, after cooler (6) Rotor, IMDOP Oil pump (7) Regulating valve regeneration airCi Intercooler with integrated drain collectorGC Oil sump (gear casing)EWDi Electronic drain, intercoolerCo Oil coolerEh High-pressure compressor elementOF Oil filterEl Low-pressure compressor elementFN1 Cooling fan (ZT)1.3 Main emphasis on quality critical issues1.3.1 GMP Risk AssessmentThe air compressor installation will be in compliance with the valid Project Qualification Master Plan, Doc. No. EPCP_01_00_HLD_QMP, EPCP_11_03_CA_FRA in their current version.1.3.2 Critical measurement instrumentsInstruments for : Operating pressure, Dew point and Temperature.1.3.3 Critical items/functionsSpecification for construction material of operational parts.Air drying process.1.3.4 Qualification strategyThe air compressor qualification is covered by the following documents:URS,GMP and Functional Risk AssessmentQualification Protocol (QP)DQ, IQ & OQQualification Report (QR).Notes:1. No separate CSV Qualification Protocol and Qualification Report are needed since itis a Class 4 system.2. A 21CFR Part 11 Risk Assessment is not requested because the control system is notable to store any data.3. The air compressor and its auxiliaries will be commissioned with the support of aVendor Engineer.5. T he Qualification (DQ/IQ/OQ) will be prepared by BNP’s own Engineers, based onthis QP. The Qualification Documentation will be prepared by Luwa.6. The calibration during IQ will be executed by the vendor technician supervised byBNP R&M engineers.7. The qualification strategy and tests scope will be based on the qualification of theexisting air compressor (same supplier, same type). No new GMP and Risk Assessment will be prepared.2. Steps covered in this ProtocolFor the Qualification of the air compressor, the present QP will be followed. The qualification documents for the air compressor will be created (DL and DQ, IQ, OQ) and will be filed with this qualification.NB: This Qualification plan does not include interfacing utilities. For information about the qualification of the CA system, see EPCP_11_03_CA_QP in its current version.Design Qualification (DQ): yes: no: NA: Commissioning (GEP) 1): yes: no: NA: Installations Qualification (IQ): yes: no: NA: Operational Qualification (OQ): yes: no: NA: Operational Qualification (PQ) 2): yes: no: NA:1) Only FAT and correct installation before IQ (SAT)2) PQ will be done by checking the Pressure and microbial test at the exhaust of the new air compressor. No water content testing will be made as the dryness and oil free status is certified by the manufacturer.Copies of the certificates will be filed in the qualification binder.3. Documentation3.1 Qualification Documents List (GPE_FRM_511_0071)Refer to “Qualification Document List for the air com pressor, EPCP_11_03_CA_COMP04_DL” in its current version.3.2 Project Specific SOP’sNo project specific SOPs for the commissioning execution of this new air compressor.3.3 Administration of DocumentsThe Documents are filed according to “Document Management Syst em:Doc. No EPCP_01_00_HLD_DMS” in its current version.4. Basics4.1 Basic SOP’sGPE_SOP_508_0484: Concept for Commissioning and QualificationEPCP-SOP-001: CommissioningGPE_SOP_511_0042: Specification, Execution and Deviation Resolution of TestsGPE_SOP_511_0030 Handling of Changes (Engineering Projects)4.2 Project Specific AgreementsTwo types of training activities will be conducted one training for qualification execution and an other training for operation and maintenance.Qualification execution training is mandatory for all persons taking part in the qualification work. The training will be conducted by Luwa, and each test person shall complete the training before the empowerment to execute qualification and commissioning activities. Operation and maintenance training will be conducted by the EPCP or the vendor. Luwa operators, engineers or technicians should complete the training based on the functional requirements.Luwa Persoamal Training Record (FRM_000037) and Training Record (FRM_000039) will be used to document the training.5. Qualification Activities (Action Plan)5.1 Project Time ScheduleRefer to project time schedule in its current version.5.2 Qualification Activities (included in Project Time Schedule)All qualification activities are summarized in “Section 1.3 Main emphasis on quality critical issues”, “Section 3.1 Qualification Documents List”.6. Organization / Responsibility6.1 Qualification OrganizationRefer to “Qualification Master Plan, EPCP_01_00_HLD_QMP” for responsibilities matrix. 6.2 Project OrganizationThe organization is within the current EPCP organization chart in PPM.7. Attachments to ProtocolAttachment 1 Qualification Document List for air new compressor,EPCP_11_03_CA_COMP04_DL in its current version.。
制药工程GMP(清洁验证)

总残留量最大允许界限 X棉签取样面积 X 取样效率 设备内总表面积 X 棉签使用溶剂量
取样及检验方法
微生物检验
棉签取样检验 最终冲洗水取样检验
总有机碳(TOC)测试
– 测量擦洗或冲洗后的水样中总有机碳的量
淋洗法取样
该方法是用已知溶剂量来淋洗设备表面。 一般淋洗样品适用于可以最后淋洗的密闭设 备;如果可能应对整个设备体系进行淋洗。
淋洗法取样
优势 适合在线检测 出结果快 取样简单 适用于大面积和难以达 到的位置取样 仅表面取样 多种药物残渣可以溶出 可以加大溶剂/冲洗水 的量,增加药物残渣的 溶出 劣势 不能直接在表面取样 残渣的溶解性取决于溶 剂的性能 检验量大 冲洗溶剂的用量大 冲洗水样可能要求浓缩 或预先浸出 不能保证相同性质的溶 出物
分析方法选择 和验证
当可接受标准量很小时, 样品处理方法: <1> 对照品溶液加入法 <2> 增加取样面积或取样量 <3> 浓缩法
活性物质残留限度的确定
与生物活性有关的限度
–
最大可允许进入后续产品中的残留物总量: 产品活性强度(最小值)X产品批量(最小值) 日服用剂量(最大值)
产品活性强度
良好的清洁结果的重要性
降低交叉污染的风险 使得产品受污染报废的可能性最小 患者的负面效应可能性最小 降低产品投诉的发生率 降低卫生部门或其他机构检查不合格的风险 延长设备的使用寿命
设备清洁的类型
手工清洗
*
由操作人员用擦洗或用高压软管等进行的清洗
自动清洗
*
由自动控制系统进行洗刷直至干燥的清洗
洁净空调确认计划(英文版)

Qualification Plan for AHU19 SystemDistribution list:AuthorLuwa Qualification Coordinator (Original)Reason for Change1. Short Description of Project / Facility / System1.1 Project DescriptionThis Qualification Plan defines the qualification activities, procedures, andresponsibilities for the secondary packing HVAC System AHU19, as part of theoverall qualification effort for the “Extension of Production Facility ChangPing” ofBeijing Luwa Pharma. Ltd., ChangPing Plant.For general information, see the following documents in its current version:Project URS Doc. No. EPCP_01_00_HLD_ URSHVAC URS Doc. No. EPCP_11_08_HVAC_URSQualification Master Plan (QMP) Doc. No. EPCP_01_00_HLD_QMPQualification Need Assessment (QNA) Doc. No. EPCP_01_00_HLD_QNA 1.2 Functional DescriptionThe secondary packing area is classified as a Luwa Zone 3 area, which comprise the following rooms:A-407 Packaging AreaA-409 Packaging Waste Air LockAHU19 is supplied with preconditioned air from PCU1. Further air treatments within the AHU19 are in the following way:∙Cooling coil (AHU)∙Heating coil (AHU)∙Fan (AHU)∙Silencer (AHU)∙Filter F9 (AHU)For the return air from AHU19 will be treated in the following way:∙Filter G4 (filter in the room)∙Fan (AHU)Then back to AHU19 and PCU1 as recirculation air.For detail information, refer to AHU19 PID (Doc. No. EPCP_11_08_AHU19_PID) and Function Specification (Doc. No. EPCP_11_08_AHU19_FS) in its currentsversion.1.3 Main Emphasis on Quality Critical Issues1.3.1 GMP Risk AssessmentIn the URS for HVAC System (Doc. No. EPCP_11_08_HVAC_URS), eachrequirement is assessed for GMP Relevance.A “GMP and Functional Risk Assessment for AHU systems” (Doc. No.EPCP_11_08_HVAC_RA) defines the critical qualification activities, which is thebasis for this qualification plan.For general information, see the overall Project “GMP Risk Assessment” (Doc. No.EPCP_11_00_HLD_GMPRA).1.3.2 Critical Measurement InstrumentsA list of instruments will be prepared for DQ and approved before IQ execution. Allcritical sensors which shall be calibrated periodically will be defined in the calibration list according to the sensor risk assessment.2 Steps Covered in this Qualification PlanDesign Qualification (DQ) Yes: No: N/A:Installations Qualification (IQ) Yes: No: N/A:Operational Qualification (OQ) Yes: No: N/A:Performance Qualification (PQ) Yes: No: N/A:3 Documentation3.1 Qualification Documents ListThe “Qualification Document List” (Doc. No. EPCP_11_08_AHU19_DL) outlines the documents to be prepared, assigned to the different Qualification Phases.The list will be updated in each qualification phase and finally completed and attached to the qualification report.3.2 Administration of DocumentsThe Qualification Coordinator from MAM is responsible for the entire documentation until handover to the Luwa.Documents are filed according to “Project Documentation Management System” (Doc.No. EPCP_01_00_HLD_DMS in its current version).4 Basics4.1 Basic SOP’sGPE_SOP_508_0484: Concept for Commissioning and Qualification (SOP-0019069) EPCP_PSOP_001: Commissioning for Facility and EquipmentGPE_SOP_511_0042: Specification, Execution and Deviation Resolution of Tests4.2 Project Specific Agreements4.2.1 Additional SOP’s from Luwa GPEGPE_SOP_511_0030: Handling of Changes in Engineering Projects4.2.2 TrainingTwo types of training activities will be conducted - training for qualification execution and training for operation and maintenance.Qualification execution training is mandatory for all persons taking part in thequalification work. The training will be conducted by MAM, and each test personshall complete the training before any test activities such as DQ, IQ, OQ and PQ canstart.Operation and maintenance training will be conducted by relevant supplier. The Luwa operators and maintenance technicians shall complete the training before PQ testactivities. Luwa PersoMAMl Training Record (FRM_000037) and Training Record(FRM_000039) shall be used to document the training.4.2.3 Specific indication for the qualification AHU19In order to ensure the generally project schedule, it was necessary to create severalGEP related documents earlier than this qualification plan. (e.g. duct leakage test,hydraulic test)5 Qualification Activities (Action Plan)5.1 Project Time ScheduleSee Project Time Schedule in its current version.5.2 Qualification Rules and Sequence of Activities5.2.1 General Qualification ProcessThe qualification process will be based on the URS, Risk Assessment andQualification Plan, DQ/IQ/OQ/PQ test specifications. The test results will besummarized in the Qualification Report.5.2.2 DQDQ documents that the design of HVAC system fulfills the URS and GMP RiskAssessment.The Design is qualified when all design documents are marked with a signed DQstamp or approved with approval signatures.DQ confirms the details of the technical design.Scope of DQ:All relevant design documents, are defined in the Qualification Documents List, shall be qualified and filed in the Test Binder.The DQ is completed when the DQ Release Form is signed by all relevant approvers.When DQ is completed the formal Project Change Control Procedure will be in effect,see “Project Documentation Management System” (Doc. No.EPCP_01_00_HLD_DMS).5.2.3 Installation Qualification (IQ)IQ contains a series of tests which documents that the system has been appropriatelyinstalled on Site.IQ pre-requisites:∙The DQ release form have to be signed by all relevant approvers∙All documents on the Qualification Documents List must be available and filed in the Test Binder∙All IQ Test Specifications have to be approved by Luwa before test activities can begin∙All test instruments shall be calibrated and have calibration certificates IQ tests are listed in the IQ Test Specification.All deviations found during IQ execution will be handled according to the deviationmanagement concept described in section 5.2.6.The IQ is complete when the IQ Release Form is signed by all relevant approvers.5.2.4 Operation Qualification (OQ)OQ contains a series of tests which documents that the system’s function performs asdescribed in the Functional Specification.OQ pre-requisites:∙The IQ release form has to be signed by all relevant approvers.∙All documents on the Qualification Documents List must be available and filed in the Test Binder∙All OQ Test Specifications have to be approved by Luwa before test activities can begin∙All test instruments shall be calibrated and have calibration certificates∙The system is commissioned and the release form signed by relevant approvers.The OQ will be executed in two phases: HVAC equipment and HVAC automationsystem.OQ tests are listed in the OQ Test Specification.All deviations found during OQ execution will be handled according to the deviationmanagement concept described in section 5.2.6.The OQ is complete when the OQ Release Form is signed by all relevant approvers.5.2.5 Performance Qualification (PQ)PQ contains a series of tests which documents that the HVAC system and thecoMAM cted rooms’ performance are in compliance with the Zoning Diagram and theURS.PQ pre-requisites:∙The OQ release form have to be signed by all relevant approvers∙All documents on the Qualification Document List must be available and filed in the Test Binder∙All PQ Test Specifications have to be approved by Luwa before test activities can begin∙All test instruments shall be calibrated and have calibration certificates∙The HVAC system and the coMAMcted rooms must be cleaned and checked according to approved cleaning SOPs.The PQ will be executed in two phases: PQ at rest and PQ in operation.5.2.5.1 PQ at restPQ at rest comprises the tests in the PQ Test Specification.All deviatio ns found during PQ “at rest” execution will be handled according to thedeviation handling SOP-000002.The PQ at rest is complete when the PQ at rest Release Form is signed by all relevant approvers.5.2.5.2 PQ in operationPQ in operation comprises the tests in the PQ Test Specification.PQ in operation shall be executed under normal operation conditions.All deviations found during PQ “in operation” execution will be handled accordingto the deviation handling SOP-000002.The PQ in operation is complete when the PQ in operation Release Form is signedby all relevant approvers.5.2.6 Qualification Deficiency / Deviation5.2.6.1 Deficiency / Deviation ListDeficiency / Deviation List is used in DQ/IQ/OQ phase.The Deficiency / Deviation List will be used to track open items which arise duringthe course of each phase.For Deviation in PQ “at rest and in operation” see 5.2.5.1 and 5.2.5.25.2.6.2 Deviation FormDeviation form is used in the IQ/OQ phase.A consecutive numbers starting at AHU19_xQ_DEV001.The proposal for corrective action must be proposed by test engineer and approvedby BNP discipline engineer.The implementation and re-inspection of corrective action must be finally approvedby the BNP discipline engineer.5.2.7 Release FormThe “Release Form” (Basic Doc. No.: EPCP_511_0067) for IQ/OQ/PQ/Productionshall be used to release each qualification phase. Without an approved release from the prior phase the next qualification phase can not begin.A copy of the test “Deficiency list” shall be attached to the “Release Form” forrespective qualification phase.5.2.8 Qualification ReportWhen the PQ “at rest” is completed, the Qualification Report (QR) will be prepared,and it will summarize all qualification activities and results from DQ, IQ, OQ and PQ “at rest“.The Qualification Report verifies that all qualification activities described in theQualification Plan, except PQ “in operation“, have been successfully performed andfulfills the accept criteria. Further more, that all observed deviations have beenhandled and closed successfully.A fter the PQ “in operation“, a Final Report will be prepared, which summarizes allactivities and results from the PQ in operation phase.The approved QR and Final Report combined confirm that the qualification iscompleted and the system is fully qualified.6 Organization / Responsibility6.1 Qualification OrganizationPeople from Luwa, MAM, Sauter and Xinxing will participate in the qualification of the AHU19 system.6.2 ResponsibilityThe responsibility of the MAM Quality Engineer:∙Prepare the QP and collect corresponding documents according to the agreed responsibility matrix Doc. No. EPCP_08_00_HVAC_RM in its current version The responsibility of the MAM Project Engineer:∙Secure correct systems description and that all technical issues are correct and meet the technical requirements∙Ensure that scope and contents are adequateThe responsibility of the MAM QA:∙Secure compliance with the EPCP_HLD and cGMP∙Secure correct referencesThe BNP responsibility:∙See QMP Responsibilities Matrix Qualification Master Plan (QMP) in its current versionDoc. No. EPCP_01_00_HLD_QMPIn general, all the responsibilities of Luwa, MAM, Sauter, Xinxing are defined in theHVAC Responsibility Matrix Doc. No. EPCP_08_00_HVAC_RM in its current version.7 AbbreviationAHU Air Handling UnitBNP Beijing Luwa PharmaDMS Document Management SystemEPCP Extension Project ChangPingFRM FormGPE Luwa Global Pharma EngineeringGMP Good Manufacturing PracticeHLD High Level DocumentHVAC Heating, Ventilation and Air ConditioningIQ Installation QualificationMAM MAM (Tianjin) Co., Ltd.OQ Operation QualificationPQ Performance QualificationQA Quality AssuranceQP Qualification PlanQMP Qualification Master PlanQNA Qualification Need AssessmentQR Qualification ReportTS Test SpecificationSOP Standard Operating ProcedureURS User Requirement Specification8 AMAMxAMAMx 1 Qualification Document List (Doc No. EPCP_11_08_AHU19_DL)。
GMP中英文对照

GMP相关的英文缩写1. AQAI(Automated Quality Assurance Inspection Equipment):在线自动质量保证检查设备.2. API(Active Pharmaceutical Ingredient):活性药物物质,即原料药.3. ANDA (Abbreviated New Drug Application):简化新药申请.4. ADR(Adverse Drug Reaction):不良反应.5. BSE(Bovine Spongiform Encephalopathy):疯牛病.6. BPCS(Business Planning and Control System):业务计划及控制系统.7. BIA(Business impact assessment): 商业影响评估.8. cGMP(current Good Manufacturing Practice):现行药品生产质量管理规范.9. CCCD(China Certification Committee for Drugs):中国药品认证委员会.10. CIP(Cleaning In Place):在线清洁. 11. CV(Concurrent Validation):同步验证.12. CDER( Center for Drug Evaluation and Research): 药品研究与评价中心.13. COA(Certificate Of Analysis):分析报告单.14. CFR(Code of Federal Regulation):(美国)联邦法规.15. CDC(Centers for Disease Control and Prevention):疾病预防控制中心.16. COS / CEP( Certificate of Suitability for European Pharmacopeia ):欧洲药典适用性证书.17. CCD (Certification Committee for Drugs):药品认证管理中心. 18. CPMP(Committee for Proprietary Medicinal Products): 欧洲专利药品委员会.19. CTD(Common Technical Document):通用技术文件.20. CDC( Centers for Disease Control and Prevention): 疾病预防控制中心.21. GMP(Good Manufacturing Practice):药品生产质量管理规范. 22. ICH(International Conference on Harmonization of Technical Requ irements for Registration of Pharmaceuticals for Human Use):人用药品注册技术要求国际协调会. 23. EU(European Union):欧洲联盟.24. EFPIA(European Federation of Pharmaceutical Industries Associations ):欧洲制药工业协会联合会.25. MHW(Ministry of Health and Welfare,Japan):日本厚生省. 26. JPMA(Japan Pharmaceutical Manufacturers Association):日本制药工业协会.27. FDA(US Food and Drug Adminiistration):美国食品与药品管理局.28. PRMA(Pharmaceutical Research and Manufacturers of America):美国药物研究和生产联合会.29. WHO(World Health Organization):世界卫生组织.30. IFPMA(International Federation of Pharmaceutical Manufacturers As sociations):国际制药工业协会联合会.31. TQC(Total Quality Control),TQM(Total Quality Management): 全面质量管理.32. PDCA(Plan,Do,Check,Action):计划,执行,检查,处理.33. QA(Quality Assurance):质量保证.34. QC (Quality Control):质量控制.35. QS(Quality System):质量体系.36. QM(Quality Management): 质量管理.37. SOP(Standard Operating Procedure): 标准操作规程.38. SMP(Standard Management Procedure):标准管理程序.39. SOR(Standard Operating Record): 标准操作记录.40. GEP(Good Engineering Practice):工程设计规范.41. HVAC(Heating Ventilation and Air Conditioning):空调净化系统.42. DQ(Design Qualification):设计确认.43. IQ(Installation Qualification):安装确认.44. OQ(Operational Qualification):运行确认.45. PQ(Performance Qualification):性能确认.46. OOS(Out-Of-Specification):检验不合格;超标.47. PFDS(Process Flow Diagrams):工艺流程图.48. MRA(cMutual Reognition Agreements): 现场检查多边认同协议.49. DMF( Drug Master File):药物主文件.50. EDMF(European Drug Master File)欧盟药物主文件.51. EDQM(European Directorate for Quality Medicines): 欧洲药品质量管理局.52. ORA(Office of Regulatory Affairs):药政事务办公室.53. GGPs( Good Guidance Practices): 优良指南规范.54. MOA(Method Of Analysis):分析方法.55. VMP(Validation Master Plan):验证主计划.56. VP(Validation Protocol):验证方案.57. MSDS(Material Safety Data Sheet):物料安全技术说明书.58. NDA (New Drug Application):新药申请.59. OTC(Over-the-counter):非处方.60. INN(International Nonproprietary Name):国际非专有名称.61. USP(the united state pharmacopeia): 美国药典.62. NF(National Formulary):(美国)国家药品集.63. GAP(Good Agricultural Practice):中药材种植管理规范.64. GCP(Good Clinical Practice):药物临床试验质量管理规范.65. GLP(Good Laboratory Practice):药物实验室管理规范.66. GSP(Good Supply Practice):药品经营质量管理规范.67. GUP(Good Use Practice):药品使用质量管理规范.68. SM(Starting Material):起始物料.69. PMF(Plant Master File); SMF(Site Master File):工厂主文件.70. EDL(List of Essential Drugs ) : 基本药物目录.71. PI(Package Insert):说明书.72. PCT( Patent Cooperation Treaty): 专利合作条约.73. PPAC(Patent Protection Association of China):中国专利保护协会.74. PIC( Person In Charge) :负责人.75. PDS(Pharmaceutical Development Services): 整体新药研发机构.76. SPC(Summary of Product Characteristics):产品特性摘要.。
制药工程GMP(清洁验证)

100 mg
微生物取样
对难以接触的表面用棉签取样
对平直表面用RODAC板
微生物取样应在化学取样前进行
清洁验证检验方法
检验方法对于分析物是特定的
检验方法必须经过验证
– 专属性 – 灵敏度 – 精密度 – 线性范围
– 回收率(取样和检验)
分析方法选 择和验证
常用的分析 方法:
分析方法选 择和验证
良好的清洁结果的重要性
降低交叉污染的风险 使得产品受污染报废的可能性最小 患者的负面效应可能性最小 降低产品投诉的发生率 降低卫生部门或其他机构检查不合格的风险 延长设备的使用寿命
设备清洁的类型
手工清洗
*
由操作人员用擦洗或用高压软管等进行的清洗
自动清洗
*
由自动控制系统进行洗刷直至干燥的清洗
清
洗
验
证
第八十四条 应当按照详细规定的操作规程清洁 生产设备。 生产设备清洁的操作规程应当规定具体而完 整的清洁方法、清洁用设备或工具、清洁剂的名 称和配制方法、去除前一批次标识的方法、保护 已清洁设备在使用前免受污染的方法、已清洁设 备最长的保存时限、使用前检查设备清洁状况的 方法,使操作者能以可重现的、有效的方式对各 类设备进行清洁。
清洁规程要点
拆卸(程度)要求 每一步的清洗要求 – 浸泡/预冲洗/清洗/喷淋时间、温度要求 – 清洗剂名称/浓度/数量/配制方法 – 清洁工具要求 消毒/灭菌,方法及相关参数 干燥方法 清洁后检查要求
清洁规程要点
生产结束至开始清洁的最长时间要求 设备连续使用的最长时间 清洁后设备的储存和条件 已清洁设备的最长存放时间 设备的清洁状况标识 过清洁有效期设备的处理 设备使用前的检查 装配要求
某公司已过新版GMP认证洁净厂房验证模版(中英文)
CleanRoomInstallationQualificationProtocol干净室安装确认方案SystemNo.系统编号:CLR-01Index名目1. Purpose目的本安装确认方案的目的是测试、检查和干净室是按照相应设计要求和需求商的建议进行安装的。
安装确认的测试和检查的结果将按照该验证方案进行记录。
安装确认将确定直截了当妨碍系统的要害部件被正确地安装,并符合设计文件需求;确定支持文件、质量文件在现场。
测试和检查的结果将按照该验证方案进行记录。
2. Scope范围本方案确定了***********公司口服固体工程车间的干净室〔位号:***********〕的安装确认。
3. Responsibility职责4. RegulationandGuidance法规和指南(SFDA)GMP2021版中国药典2021版现行版ISPE指南5“调试和确认〞干净厂房设计标准GB13554-92 5. Abbreviations缩略语6. SystemDescription系统描述口服固体制剂的干净室包括以下级不D级区非要害生产步骤的干净区对产品无妨碍的房间无需验证。
7. GoodDocumentationPractice文件治理标准记录用笔:- 使用不消退的墨水笔和记号笔,推举使用蓝色笔记录签名:- 被授权的人员才能签署文件- 应签全名,除非文件另有规定- 签名应该是可识不的- 签名应始终一致填写栏目:- 所有栏目必须填写- 填写内容与上面栏目相同应重新填写- 假设有单个栏目不需要填进内容,那么在空白处填写英文字母“不适用〞的简写“N/A〞,以表示无此项内容。
- 填写记录时,假设有多个栏目不需要填进内容,应用歪线划掉,歪线上方填写“N/A,下方签名和注明日期。
签名及日期应尽量沿歪线同侧填写。
文件刚完成,马上更改的在错误处划线,填进正确的,签名和注明更改日期,确保原先信息仍清楚可识不如:2010年01月01日签字,日期事后更改的,除非马上更改的要求外,还应注明更改的缘故,检查和注释可能的妨碍。
ICH q7a (中英文对照)
Q7a(中英文对照)FDA原料药GMP指南Table of Contents 目录1. INTRODUCTION 1. 简介1.1 Objective 1.1目的1.2 Regulatory Applicability 1.2法规的适用性1.3 Scope 1.3范围2. QUALITY MANAGEMENT 2.质量管理2.1 Principles 2.1总则2.2 Responsibilities of the Quality Unit(s) 2.2质量部门的责任2.3 Responsibility for Production Activities 2.3生产作业的职责2.4 Internal Audits (Self Inspection) 2.4内部审计(自检)2.5 Product Quality Review 2.5产品质量审核3. PERSONNEL 3. 人员3.1 Personnel Qualifications 3.人员的资质3.2 Personnel Hygiene 3.2 人员卫生3.3 Consultants 3.3 顾问4. BUILDINGS AND FACILITIES 4. 建筑和设施4.1 Design and Construction 4.1 设计和结构4.2 Utilities 4.2 公用设施4.3 Water 4.3 水4.4 Containment 4.4 限制4.5 Lighting 4.5 照明4.6 Sewage and Refuse 4.6 排污和垃圾4.7 Sanitation and Maintenance 4.7 卫生和保养5. PROCESS EQUIPMENT 5. 工艺设备5.1 Design and Construction 5.1 设计和结构5.2 Equipment Maintenance and Cleaning 5.2 设备保养和清洁5.3 Calibration 5.3 校验5.4 Computerized Systems 5.4 计算机控制系统6. DOCUMENTATION AND RECORDS 6. 文件和记录6.1 Documentation System and 6.1 文件系统和质量标准Specifications6.2 Equipment cleaning and Use Record 6.2 设备的清洁和使用记录6.3 Records of Raw Materials, Intermediates, API Labeling and Packaging Materials 6.3 原料、中间体、原料药的标签和包装材料的记录6.4 Master Production Instructions (MasterProduction and Control Records)6.4 生产工艺规程(主生产和控制记录)6.5 Batch Production Records (BatchProduction and Control Records)6.5 批生产记录(批生产和控制记录)6.6 Laboratory Control Records 6.6 实验室控制记录6.7 Batch Production Record Review 6.7批生产记录审核7. MATERIALS MANAGEMENT 7. 物料管理7.1 General Controls 7.1 控制通则7.2 Receipt and Quarantine 7.2接收和待验7.3 Sampling and Testing of IncomingProduction Materials7.3 进厂物料的取样与测试7.4 Storage 7.4储存7.5 Re-evaluation 7.5复验8. PRODUCTION AND IN-PROCESSCONTROLS8. 生产和过程控制8.1 Production Operations 8.1 生产操作8.2 Time Limits 8.2 时限8.3 In-process Sampling and Controls 8.3 工序取样和控制8.4 Blending Batches of Intermediates orAPIs8.4 中间体或原料药的混批8.5 Contamination Control 8.5 污染控制9. PACKAGING AND IDENTIFICATIONLABELING OF APIs ANDINTERMEDIATES9. 原料药和中间体的包装和贴签9.1 General 9.1 总则9.2 Packaging Materials 9.2 包装材料9.3 Label Issuance and Control 9.3 标签发放与控制9.4 Packaging and Labeling Operations 9.4 包装和贴签操作10. STORAGE AND DISTRIBUTION 10.储存和分发10.1 Warehousing Procedures 10.1 入库程序10.2 Distribution Procedures 10.2 分发程序11. LABORATORY CONTROLS 11.实验室控制11.1 General Controls 11.1 控制通则11.2 Testing of Intermediates and APIs 11.2 中间体和原料药的测试11.3 Validation of Analytical Procedures 11.3 分析方法的验证11.4 Certificates of Analysis 11.4 分析报告单11.5 Stability Monitoring of APIs 11.5 原料药的稳定性监测11.6 Expiry and Retest Dating 11.6 有效期和复验期11.7 Reserve/Retention Samples 11.7 留样12. V ALIDATION 12.验证12.1 Validation Policy 12.1 验证方针12.2 Validation Documentation 12.2 验证文件12.3 Qualification 12.3 确认12.4 Approaches to Process Validation 12.4 工艺验证的方法12.5 Process Validation Program 12.5 工艺验证的程序12.6 Periodic Review of Validated Systems 12.6验证系统的定期审核12.7 Cleaning Validation 12.7 清洗验证12.8 Validation of Analytical Methods 12.8 分析方法的验证13. CHANGE CONTROL 13.变更的控制14. REJECTION AND RE-USE OFMATERIALS14.拒收和物料的再利用14.1 Rejection 14.1 拒收14.2 Reprocessing 14.2 返工14.3 Reworking 14.3 重新加工14.4 Recovery of Materials and Solvents 14.4 物料与溶剂的回收14.5 Returns 14.5 退货15. COMPLAINTS AND RECALLS 15.投诉与召回16. CONTRACT MANUFACTURERS(INCLUDING LABORATORIES)16.协议生产商(包括实验室)17. AGENTS, BROKERS, TRADERS, DISTRIBUTORS, REPACKERS, AND RELABELLERS 17.代理商、经纪人、贸易商、经销商、重新包装者和重新贴签者17.1 Applicability 17.1适用性17.2 Traceability of Distributed APIs andIntermediates17.2已分发的原料药和中间体的可追溯性17.3 Quality Management 17.3质量管理17.4 Repackaging, Relabeling, and Holding of APIs and Intermediates 17.4原料药和中间体的重新包装、重新贴签和待检17.5 Stability 17.5稳定性17.6 Transfer of Information 17.6 信息的传达17.7 Handling of Complaints and Recalls 17.7 投诉和召回的处理17.8 Handling of Returns 17.8 退货的处理18. Specific Guidance for APIs Manufactured by Cell Culture/Fermentation 18. 用细胞繁殖/发酵生产的原料药的特殊指南18.1 General 18.1 总则18.2 Cell Bank Maintenance and RecordKeeping18.2细胞库的维护和记录的保存18.3 Cell Culture/Fermentation 18.3细胞繁殖/发酵18.4 Harvesting, Isolation and Purification 18.4收取、分离和精制18.5 Viral Removal/Inactivation steps 18.5 病毒的去除/灭活步骤19.APIs for Use in Clinical Trials 19.用于临床研究的原料药19.1 General 19.1 总则19.2 Quality 19.2 质量19.3 Equipment and Facilities 19.3 设备和设施19.4 Control of Raw Materials 19.4 原料的控制19.5 Production 19.5 生产19.6 Validation 19.6 验证19.7 Changes 19.7 变更19.8 Laboratory Controls 19.8 实验室控制19.9 Documentation 19.9 文件20. Glossary 20. 术语Q7a GMP Guidance for APIs Q7a原料药的GMP指南1. INTRODUCTION 1. 简介1.1 Objective 1.1目的This document is intended to provide guidance regarding good manufacturing practice (GMP) for the manufacturing of active pharmaceutical ingredients (APIs) under an appropriate system for managing quality. It is also intended to help ensure that APIs meet the quality and purity characteristics that they purport, or are represented, to possess. 本文件旨在为在合适的质量管理体系下制造活性药用成分(以下称原料药)提供有关优良药品生产管理规范(GMP)提供指南。
PIC S VMP 验证主计划(中英文对照)
OPERATIONAL QUALIFICATION STERILE PROCESS VALIDATIONCLEANING VALIDATION (1/25)1. DOCUMENT HISTORYAdoption by PIC/S Committee 10 - 11 December 1998Entry into force of version PR 1/99-1 01 March 1999Entry into force of version PI 006-1 01 September 20012. INTRODUCTIONThe basic principles and application of qualification and validation are describedin Annex 15 to the PIC/S and EU Guide to GMP. This document comprises individual Recommendations on four topics relating to Equipment Qualification and Process Validation in pharmaceutical manufacture, as follows:Ø Validation Master PlanØ Installation and Operational QualificationØ Non-Sterile Process ValidationØ Cleaning ValidationThe four Recommendations comprising this document define general principles pertaining to each of the topics.2. 导言PIC/S和EU GMP指导原则的附录15中对确认(Qualification)和验证(Validation)的基本原则及应用进行了阐述。
洁净词汇中英文对照
GMP英语PIC/S的全称为:Pharmaceutical InspectionConvention/Pharmaceutical Inspection Cooperation Scheme, PIC/S(制药检查草案), 药品检查协会(PIC/S) ,也有人称PIC/S为医药审查会议/合作计划(PIC/S)PIC的权威翻译:药品生产检查相互承认公约API(Active Pharmaceutical Ingredient) 原料药又称:活性药物组分Air Lock 气闸Authorized Person 授权人Batch/Lot 批次Batch Number/Lot-Number 批号;Batch Numbering System 批次编码系统;Batch Records 批记录;Bulk Product 待包装品;Calibration 校正;Clean area洁净区;Consignment(Delivery)托销药品。
FDA(FOOD AND DRUG ADMINISTRATION):(美国)食品药品管理局IND(INVESTIGATIONAL NEW DRUG):临床研究申请(指申报阶段,相对于NDA而言);研究中的新药(指新药开发阶段,相对于新药而言,即临床前研究结束)NDA(NEW DRUG APPLICATION):新药申请ANDA(ABBREVIATED NEW DRUG APPLICATION):简化新药申请TREATMENT IND:研究中的新药用于治疗ABBREVIATED(NEW)DRUG:简化申请的新药DMF(DRUG MASTER FILE):药物主文件(持有者为谨慎起见而准备的保密资料,可以包括一个或多个人用药物在制备、加工、包装和贮存过程中所涉及的设备、生产过程或物品。
只有在DMF持有者或授权代表以授权书的形式授权给FDA,FDA在审查IND、NDA、ANDA时才能参考其内容)HOLDER:DMF持有者CFR(CODE OF FEDERAL REGULATION):(美国)联邦法规PANEL:专家小组BATCH PRODUCTION:批量生产;分批生产BATCH PRODUCTION RECORDS:生产批号记录POST-OR PRE- MARKET SURVEILLANCE:销售前或销售后监督INFORMED CONSENT:知情同意(患者对治疗或受试者对医疗试验了解后表示同意接受治疗或试验)PREscriptION DRUG:处方药OTC DRUG(OVER—THE—COUNTER DRUG):非处方药GMP文件常见缩写ABPI Association of the British Pharmaceutical Industry ADR Adverse Drug Reaction AE Adverse EventAIM Active Ingredient ManufacturerANDA Abbreviated New Drug ApplicationANOVA Analysis of VarianceASM: Active Substance ManufacturerATC Anatomical Therapeutic ChemicalATX Animal Test Exemption CertificateBAN British Approved NameBIRA British Institute of Regulatory AffairsBNF British National FormularyBP British PharmacopoeiaC of A Certificate of AnalysisC of S Certificate of SuitabilityCENTRE FOR DRUG EVALUATION (CDE)Centre for Pharmaceutical Administration (CPA)CMS Concerned Member State CMS每个成员国COS Certificate of SuitabilityCPMP Committee for Proprietary Medicinal Products CRA Clinical Research AssociateCRF Case Report FormCRO Contract Research OrganizationCTA Clinical Trial ApplicationCTC Clinical Trial CertificateCTD Common Technical documentCTX Clinical Trials ExemptionDDD Defined Daily DoseDGC Daily Global ComparisonDIA Drug Information AssociationDMF Drug Master FileDrug Registration Branch (DR, Product Evaluation & Registration Division, CPAEDQM (European Directorate for the Quality of Medicines) 欧洲联盟药品质量指导委员会EEA 欧洲经济地区EGMA European Generics Medicine AssociationELA Established License ApplicationEMEA European Medicines Evaluation AgencyEMEA (European Agency for the Evaluation of Medicinal Products)欧洲联盟药品评价机构EP European PharmacopoeiaEPAR European Public Assessment ReportsESRA European Society of Regulatory AffairsEuropean Pharmacopoeia Commission 欧洲药典委员会FDAFDA Food and Drug AdministrationFinal Evaluation Report (FER)Free Sale Certificates (FSCs)GCP Good Clinical Practice GCP药品临床研究管理规范GLP Good Laboratory PracticeGLP 药品临床前安全性研究质量管理规范GMP Good Manufacturing PracticeGMP 药品生产质量管理规范GSP药品销售管理规范Health Sciences Authority (HSA)HSA’s Medicines Advisory Committee (MAC)IB Investigators BrochureICH International Conference for Harmonization IDMC Independent Data-Monitoring CommitteeIEC Independent Ethics CommitteeIND Investigational New DrugINN International Non-proprietary Name International Conference on Harmonization (ICH) IPC In Process ControlIRB Institutional Review BoardLICENCE HOLDERMA Marketing AuthorizationMAA Marketing Authorization ApplicationMAA上市申请MAH Marketing Authorization HolderMAH 销售许可持有者MCA Medicines Control AgencyMHW Ministry of Health and Welfare (Japan)MR Mutual RecognitionMRA 美国与欧盟的互认协议MRAs (Mutual Recognition Agreements) 互相認證同意MRFG Mutual Recognition Facilitation GroupMRP Mutual Recognition ProcedureNAS New Active SubstanceNCE New Chemical EntityNDA New Drug ApplicationNew Chemical Entities (NCEs)New Drug Applications (NDAs)NSAID Non Steroidal Anti Inflammatory DrugNTA Notice To ApplicantsOOS Out of SpecificationOTC Over the CounterPAGB Proprietary Association of Great BritainPh Eur European PharmacopoeiaPIL Patient Information LeafletPL Product License POM Prescription Only MedicinePRODUCT OWNERPSU Periodic Safety UpdatesQA Quality AssuranceQC Quality ControlRAJ Regulatory Affairs JournalRMS Reference Member StateRMS相互认可另一成员国RSD Relative Standard DeviationRx Prescription OnlySAE Serious Adverse EventSMF Site Master FileSOP Standard Operating ProcedureSOP (STANDARD OPERATION PROCEDURE)标准运作程序SPC Summary of Product CharacteristicsTherapeutic Goods Administration (TGA)USP US PharmacopoeiaVMF Veterinary Master FileVPC Veterinary Products CommitteeA.A.A Addition and Amendments 增补和修订AC Air Conditioner 空调器ADR Adverse Drug Reaction 药物不良反应AFDO Association of Food and Drug Officials食品与药品官员协会(美国)ACC Accept 接受AQL Acceptable Quality Level 合格质量标准ADNA Abbreviated New Drug Application 简化的新药申请BOM Bill of Material 物料清单BPC Bulk pharmaceutical Chemicals 原料药CBER Center for Biologics Evaluation Research生物制品评价与研究中心CFU Colony Forming Unit 菌落形成单位DMF Drug Master File 药品管理档案CDER Center for Drug Evaluation and Research药物评价与研究中心CI Corporate Identity (Image) 企业识别(形象)CIP Cleaning in Place 在线清洗CSI Consumer Safety Inspector 消费者安全调查员CLP Cleaning Line Procedure 在线清洗程序DAL Defect Action Level 缺陷作用水平DEA Drug Enforcement Administration 管制药品管理DS documentation System 文件系统FDA Food and Drug Administration食品与药品管理局(美国)GATT General Agreement on Tariffs and Trade关贸总协会GMP Good Manufacturing Practice 药品生质量管理规范GCP Good Clinical Practice 药品临床实验管理规范GLP Good Laboratory Practice 实验室管理规范GSP Good Supply Practice 药品商业质量规范GRP Good Retail Practice 药品零售业质量管理规范GAP Good Agriculture Practice 药材生产管理规范GVP Good Validation Practice 验证管理规范GUP Good Use Practice 药品使用规范HVAC Heating Ventilation Air Conditioning空调净化系统ISO International Organization for Standardization 国际标准化组织MOU Memorandum of Understanding 谅解备忘录PF Production File 生产记录用表格OTC Over the Counter (Drug) 非处方药品PLA Product License Application 产品许可申请QA Quality Assurance 质量保证QC Quality Control 质量控制QMP Quality Management Procedure 质量管理程序SDA State Drug Administration 国家药品监督管理局SMP Standard Management Procedure 标准管理程序SOP Standard Operating Procedure 标准操作程序TQC Total Quality Control 全面质量管理USA United States Pharmacopoeia 美国药典质检专业术语1. 认可的实验室 accredited laboratory2. 提前装运通知 advanced shipment notification (ASN)3. 基准确定 benchmarking4. 经营计划 business plan5. 计算机辅助设计 computer aided design (CAD)6. 计算机辅助工程 computer aided engineering (CAE)7. 校准 calibration8. 应急计划 contingency plan9. 持续改进计划/方案continuous improvement plan/program10. 合同 contract11. 控制计划 control plan12. 纠正措施计划 corrective action plan13. 不良质量成本 cost of poor quality14. 横向职能方法 cross-functional approach15. 装配性设计 design for assembly (DFA)16. 实验设计 design of experiment (DOE)17. 设计纪录 design record18. 设计责任供方 design-responsible suppliers 19. 文件document ation20. 安全关注 due care21. 设备 equipment22. 工程批准的授权engineering approved authorization23. 执行职责 executive responsibility24. 有限元分析 finite element analysis (FEA)25. 可行性 feasibility26. 先进先出 first in first out (FIFO)27. 失效模式及后果分析failure mode and effects analysis (FMEA)28. 功能验证 functional verification29. 几何尺寸与公差geometric dimensioning & tolerancing (GD&T)30. 作业指导书 job instruction31. 实验室 laboratory32. 实验室范围 laboratory scope33. 末件比较 last off part comparison34. 全尺寸检验 layout inspection35. 防错 mistake proofing36. 多方论证方法 multi-disciplinary approach37. 运行业绩 operational performance38. 预见性维护 predictive maintenance39. 超额运费 premium freight40. 预防性维护 preventive maintenance41. 解决问题 problem solving42. 程序 procedures43. 过程审核 process audit44. 过程流程图 process flow diagram flow chart45. 产品 product46. 产品实现 product realization47. 产品审核 product audit48. 项目管理 project management49. 质量功能展开 quality function deployment (QFD)50. 质量手册 quality manual51. 反应计划 reaction plan52. 外部场所 remote location53. 重复性和再现性研究repeatability and reproducibility studies54. 现场 site55. 特殊特性 special characteristics56. 分承包方 subcontractor57. 分承包方的开发 subcontractor development58. 供方 supplier59. 投标 tender60. 工具/工装 tool/tooling更衣室 Changing Room一更 First Changing Room手消室 Hands Disinfection Room气闸室 Airlock Room洁具室 Cleaning Tools Room清洗室 Cleaning Room模具室 Dies Room内包装室 Immediate Package Room安全门 Emergency Door外包清室Outer Package Removing Room存料间Storage Room of Raw Materials粉碎室 Pulverizing Room备料室 Materials Preparing Room硬胶室 Hard Capsules Filling Room软胶室 Soft Capsules Room制粒干燥室Granulating and Drying Room总混间 Blending Room中间站 Intermediate Station压片室Tablets Room Compression Room包衣室 Coating Room配浆间 Coating Mixture Preparing Room铝塑包装间Packing Room传递窗 Transferring Window外包装室 Outer Packing Room蒸馏水室 Water Purifying Room质检室 Quality Control Room浓配室 Concentrated Solution Room稀配室 Diluted Solution Room灌封室Filling and Sealing Room存瓶室 Ampul Storage Room洗瓶室 Ampul Cleaning Room灭菌间 Sterilizing Room灯检室 Light Inspection Room粉针室 Lyophilized Sterile Powder Room冷冻干燥机 LyophilizerUrine Analyzer 尿液分析仪blood sugar(glucose ) analyzer血糖分析仪test strip 测试条reagent 试剂Semi-automatic Biochemical Analyzer半自动生化分析仪Automatic Blood Cell Analyzer全自动血细胞分析仪Urine sediments analyzer尿沉渣Bio-safety Cabinet 生物安全柜Incubator培养箱High Frequency Electrotome 高频电刀shadowless lamp无影灯High speed refrigerated centrifuge高速冷冻离心机hot air sterilizer热空气消毒箱microbiological incubator微生物培养箱Halogen light 卤素灯disposable sterile injector 一次性无菌注射针injection set注射器disposable venous infusion needle一次性静脉输液针disposable infusion set 一次性使用输液器blood transfusion set输血器infusion bag液袋urine drainage bag集尿袋blood bag血袋medical catheter医用导管stainless steel needle不锈钢医用针管blood taking needle采血针needle destroyer针头销毁器automatic packer自动纸塑包装机scalp vein set头皮针uniprocessor version单机版network version网络版macromolecule-solvent 高分子溶解的macromolecule cold accumulation 高分子蓄冷cold treatment冷疗法ice pack冰袋eyeshade 眼罩Medical injection pump医用灌注泵lithotrite 碎石机extracorporeal shock wave lithotrite体外冲击碎石机Ballistic intracroporeal lithotrite气压冲击体内碎石机Laparoscope 腹腔镜Urology 泌尿外科kidney stones 肾结石Multi-parameter monitor, 多参数监护仪maternal monitor/fetal monitor母亲/胎儿监护仪ICU monitor 重症监护仪anesthetic equipment 麻醉机respirator呼吸机electronic colposcope 电子阴道镜smog absorber烟雾吸收器digital film room 数字胶片室Permanent Magnet Open Magnetic Resonance system 永磁开放式磁共振系统Ultrasonic Color Doppler Diagnostic system彩色超声多普勒诊断系统Mobile CT system 移动CT系统X-ray Mammary Machine 乳腺X线机Mammography乳腺high precision Stereotaxic 高精度脑立体定向仪portable Type-B ultrasonic 便携式B超Sterilization and Disinfection Equipment消毒灭菌设备Radiotherapeutic equipment.放射疗法设备pharmaceutical equipments.制药设备horizontal pressurized steam sterilizer普通卧式压力蒸汽灭菌器medical electronic linear accelerator医用电子直线加速器high frequency X-rays diagnostic machine高频X射线诊断机simulated positioner模拟定位机high frequency mobile X-rays machine高频移动X射线机暖通专业词汇中英文对照(一)ahu air hundling unit 空调箱air conditioning load空调负荷air distribution气流组织air handling unit 空气处理单元air shower 风淋室air wide pre.drop空气侧压降aluninum accessaries in clean room 洁净室安装铝材as-completed drawing 修改竣工图ayout 设计图blass stop valve 铜闸阀canvas connecting termingal 帆布接头centigrade scale 摄氏温度chiller accessaries 水冷柜机排水及配料chiller asembly 水冷柜机安装工费chiller unit 水冷柜机基础clean bench 净化工作台clean class 洁净度clean room 洁净室无尘室correction factor修正系数dcc dry coll units 干盘管district cooling 区域供冷direct return system异程式系统displacement ventilation置换通风drawn No.图号elevation立面图entering air temp进风温度entering water temp进水温度fahrenheit scale 华氏温度fan coil unit 风机盘管ffu fan filter units 风扇过滤网组final 施工图flow velocity 流速fresh air supply 新风供给fresh air unit 新风处理单元ground source heat pump地源热泵gross weight 毛重heating ventilating and air conditioning供热通风与空气调节hepa high efficiency pariculate air 高效过滤网high efficiency particulate air filters高效空气过滤器horizontal series type水平串联式hot water supply system生活热水系统humidity 湿度hydraulic calculation水力计算isometric drawing轴测图leaving air temp 出风温度leaving water temp出水温度lood vacuum pump中央集尘泵mau make up air hundling unit schedule 外气空调箱natural smoke exhausting自然排烟net weight 净重noise reduction消声nominal diameter 公称直径oil-burning boiler燃油锅炉one way stop peturn valve 单向止回阀operation energy consumption运行能耗pass box 传递箱particle sizing and counting method 计径计数法Piping accessaries 水系统辅材piping asembly 配管工费plan 平面图rac recirculation air cabinet unit schedule循环组合空调单元ratio controller 比例调节器ratio flow control 流量比例控制ratio gear 变速轮 ratio meter 比率计rational 合理性的,合法的;有理解能力的rationale (基本)原理;原理的阐述rationality 有理性,合理性rationalization proposal 合理化建义ratio of compression 压缩比ratio of expansion 膨胀比ratio of run-off 径流系数ratio of slope 坡度ratio of specific heat 比热比raw 生的,原状的,粗的;未加工的raw coal 原煤 raw cotton 原棉raw crude producer gas 未净化的发生炉煤气raw data 原始数据raw fuel stock 粗燃料油raw gas 未净化的气体real gas 实际气体realignment 重新排列,改组;重新定线realm 区域,范围,领域real work 实际工作ream 铰孔,扩孔rear 后部,背面,后部的rear arch 后拱rear axle 后轴rear-fired boiler 后燃烧锅炉rear pass 后烟道rearrange 调整;重新安排[布置]rearrangement 调整,整顿;重新排列[布置] reason 理由,原因;推理reasonable 合理的,适当的reassembly 重新装配reaumur 列氏温度计reblading 重装叶片,修复叶片recalibration 重新校准[刻度]recapture 重新利用,恢复recarbonation 再碳化作用recast 另算;重作;重铸receiving basin 蓄水池receiving tank 贮槽recentralizing 恢复到中心位置;重定中心;再集中receptacle 插座[孔];容器reception of heat 吸热recessed radiator 壁龛内散热器,暗装散热器recharge well 回灌井reciprocal 倒数;相互的,相反的,住复的reciprocal action 反复作用reciprocal compressor 往复式压缩机reciprocal feed pump 往复式蒸汽机reciprocal grate 往复炉排reciprocal motion 住复式动作reciprocal proportion 反比例reciprocal steam engine 往复式蒸汽机reciprocate 往复(运动),互换reciprocating 往复的,来回的,互相的,交替的reciprocating ( grate ) bar 往复式炉排片reciprocating compressor 往复式压缩机reciprocating condensing unit 往复式冷冻机reciprocating packaged liquid chiller往复式整体型冷水机组reciprocating piston pump 往复式活塞泵reciprocating pump 往复泵,活塞泵reciprocating refrigerator 往复式制冷机recirculate 再循环recirculated 再循环的recirculated air 再循环空气[由空调场所抽出,然后通过空调装置,再送回该场所的回流空气]recirculated air by pass 循环空气旁路recircilated air intake 循环空气入口recirculated cooling system 再循环冷却系统recirculating 再循环的,回路的recirculating air duct 再循环风道recirculating fan 再循环风机recirculating line 再循环管路recirculating pump 再循环泵recirculation 再循环recirculation cooling water 再循环冷却水recirculation ratio 再循环比recirculation water 再循环水reclaim 再生,回收;翻造,修复reclaimer 回收装置;再生装置reclamation 回收,再生,再利用reclamation of condensate water蒸汽冷凝水回收recombination 再化[结]合,复合,恢复recommended level of illumination 推荐的照度标准reconnaissance 勘察,调查研究record drawing 详图、大样图、接点图recording apparatus 记录仪器recording barometer 自记气压计recording card 记录卡片recording facility 记录装置recording liquid level gauge 自动液面计recording paper of sound level 噪声级测定纸recording pressure gauge 自记压力计recording water-gauge 自记水位计recoverable 可回收的,可恢复的recoverable heat 可回收的热量recoverable oil 可回收的油recoverable waster heat 可回收的废热recovery plant 回收装置recovery rate 回收率relief damper 泄压风门return air flame plate回风百叶。
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
GMP and Functional Risk Assessment for Compressed AirGMP and Functional Risk Assessment for Compressed Air Page 1 of 15DOCUMENT HISTORYThis risk assessment serves as GMP and Functional Risk Assessment for Systems, as well as traceability matrix between requirement,potential risk, and measure to control risk (e.g. specific test specification, additional requirement to mitigate risk, SOP).Risk Assessment ProcedureStep 0 – Approval Cover Page and Document History▪The section “Risk Assessment Work Session Attendance” will be used to record work session number, list of attendees, and the work session date.▪After completion of the Risk Assessment (before executing the specific measures) the Risk Assessment will be initially approved (section “Assessment”).▪In case that the approved Risk Assessment will be revised, the initial approval of the Risk Assessment is obsolete and the revised Risk Assessment requires a new approval. The Revision Number must be adapted accordingly.▪If - all defined measures and tests are completed and- in all rows the cell “Measures completed” is assessed “Yes”then the Risk Assessment is finally approved in the section “Final Assessment Approval”.Step 1 – Description of the current process / work flowGMP and Functional Risk Assessment for Compressed Air Page 2 of 15Fill out columns “Source Document”, “Function” and “Reverse Function”▪Source Documents typically encompass the System URS, block diagram, and/or functional description, but related documents must also be considered. For example, if the 21 CFR Part 11 assessment demonstrates that the system must comply with Part 11, a row must be added in thecorresponding GMP/FRA to ensure traceability to this GMP critical requirement. Other System level “umbrella” documents, egg AutomationURS and/or Electrical URS that contain Critical GMP requirements that apply to many systems, must either have their own GMP/FRAassessments, or the GMP critical requirements traced in each System level GMP/FRA.Step 2 –Risk Assessment [column “Risk Assessment”]Probability Ratingo Low (L): Due to the design failures may not occur. The design is well known and often used.o High (H): The design is new and not well known. There is a high probability that failures occur.Impact Rating▪Which impact has the described failure, independently of the probability rating?o Low (L): No impact to the product quality.o High (H): Impact to productProbability of Detection▪Which probability of failure detection is given? Is it possible to detect the failure immediately or latest during Quality Control/batch release?o High (H): The failure will be detected immediately.o Low (L): The failure can not be detected immediately. The failure may not be detected during Quality Control tests.GMP criticality▪Assess the risk in regard to product quality and patient safety. Note: GMP criticality is not the same as GMP-relevance. GMP relevance will not be changed by application of specific measures and control. GMP criticality is reduced by proper design and control of the process. Forexample, sterilization process failures (e.g. temperature not reached during sterilization) have high GMP criticality, but proper design of thesterilizer and control of the process with sensors reduces GMP criticality. However, although GMP criticality has been reduced, the GMPrelevance of a compliant sterilization cycle remains unchanged.o High (H): There is an impact on product quality and/or patient safety and/or the impact is not under control / not acceptable.o Low (L): There is insignificant impact on product quality and/or patient safety and/or the impact is under control / acceptable.▪Record the unique URS ID number in the Reference Document column for all GMP crit ical requirements (marked “H”).▪For each GMP critical requirement, insert the specific URS requirement in the Function column.GMP and Functional Risk Assessment for Compressed Air Page 3 of 15Step 3 – Definition of specific measures to mitigate risks (columns Measures, Action)The main measures are, but not limited to:▪Definition of additional design requirements (e.g. in URS, FS) to mitigate risk▪Definition and execution of additional, specific IQ, OQ and PQ tests▪Generation of specific Standard Operating Procedures (SOPs)▪Specific operational procedures▪Additional sensors for process monitoring and control▪Calibration of quality relevant/critical sensors▪Cleaning validation▪Safety measures and arrangementsDefine and document the responsible person and the due date for the specific measure.Step 4 – Risk Assessme nt [column “Risk Assessment considering defined measures”]Assessment in view of the successful execution of all defined measures to mitigate risks.Apply the same rating as in Step2:Probability RatingThe probability of occurrence if all defined measures are implementedImpact RatingThe impact of an event usually remains the same independently of the defined measures.Probability of DetectionThe probability of detection of an event if all defined measures are implementedGMP-criticalityThe GMP-criticality must be low, otherwise additional measures must be defined.Step 5 – Execution of specific measuresGMP and Functional Risk Assessment for Compressed Air Page 4 of 15The execution and documentation of specific measures are traced and controlled via test specifications, list of critical sensors, preventive maintenanceplans, and/or open item lists.Document titles and revision should be documented in column “Test Documentation / Traceability / Reference” under the corres ponding point (DQ, IQ,…). In case of to many documents or title of document to long it is possible to include a reference (e.g. a reference to a Test Specification overview)in the column.The execution completion should be documented with initials and date in the column “Action / Responsible Due Date”.Step 6 – Measures completedAfter documented execution of all specific measures and tests to mitigate risks, the completion and closure is checked and confirmed in the last cellof each row.Step 7 – Risk Assessment CompletionAfter all measures of the entire analyses are completed (step 6 for all rows) the Risk Assessment will be finally approved on the cover page (section“Final Assessment Completion”).GMP and Functional Risk Assessment for Compressed Air Page 5 of 15GMP and Functional Risk Assessment for Compressed Air Page 6 of 15GMP and Functional Risk Assessment for Compressed Air Page 7 of 15GMP and Functional Risk Assessment for Compressed Air Page 8 of 15GMP and Functional Risk Assessment for Compressed Air Page 9 of 15GMP and Functional Risk Assessment for Compressed Air Page 10 of 15GMP and Functional Risk Assessment for Compressed Air Page 11 of 15GMP and Functional Risk Assessment for Compressed Air Page 12 of 15GMP and Functional Risk Assessment for Compressed Air Page 13 of 15GMP and Functional Risk Assessment for Compressed Air Page 14 of 15GMP and Functional Risk Assessment for Compressed Air Page 15 of 15。